about
"Redundancy" of endocannabinoid inactivation: new challenges and opportunities for pain controlAM-251 and rimonabant act as direct antagonists at mu-opioid receptors: implications for opioid/cannabinoid interaction studiesRole of cannabinoids in multiple sclerosisRole of Cannabinoids in Gastrointestinal Mucosal Defense and InflammationIn search of analgesia: emerging roles of GPCRs in pain.In vitro and in vivo characterization of the new analgesic combination Beta-caryophyllene and docosahexaenoic Acid.Impact of efficacy at the μ-opioid receptor on antinociceptive effects of combinations of μ-opioid receptor agonists and cannabinoid receptor agonists.Additive antinociceptive effects of mixtures of the κ-opioid receptor agonist spiradoline and the cannabinoid receptor agonist CP55940 in ratsInteractions between μ-opioid receptor agonists and cannabinoid receptor agonists in rhesus monkeys: antinociception, drug discrimination, and drug self-administration.Temporal changes in mouse brain fatty acid amide hydrolase activity.Interaction of the cannabinoid and opioid systems in the modulation of nociception.Interactions between Δ(9)-tetrahydrocannabinol and heroin: self-administration in rhesus monkeys.Medical marijuana use and suicide attempt in a patient with major depressive disorder.Examining the roles of cannabinoids in pain and other therapeutic indications: a review.Deciphering the mechanism(s) of action of natural products: analgesic peroxide oil as example.Pharmacokinetic evaluation of nabiximols for the treatment of multiple sclerosis pain.Pharmacology: Cannabis in neurology--a potted review.Rimonabant ameliorates insulin resistance via both adiponectin-dependent and adiponectin-independent pathways.Cannabinoid signaling in health and disease.The Central Role of Glia in Pathological Pain and the Potential of Targeting the Cannabinoid 2 Receptor for Pain Relief.Interactions between cannabinoid receptor agonists and mu opioid receptor agonists in rhesus monkeys discriminating fentanyl.The cannabinoid R+ methanandamide induces IL-6 secretion by prostate cancer PC3 cells.The medical necessity for medicinal cannabis: prospective, observational study evaluating the treatment in cancer patients on supportive or palliative care.Prescribing cannabis for harm reductionModulation of T-type Ca2+ channels by Lavender and Rosemary extracts.System-specific activity in response to Δ9 -tetrahydrocannabinol: a functional magnetic resonance imaging study in awake male rats.
P2860
Q27015753-789D201E-1F92-42AE-91BB-907F8A015977Q28270589-04B20BBA-5630-4F0F-848B-F76F2A46371CQ28305413-D27D7A24-9FE6-443D-918F-21CFACF73C84Q30357558-9C0AA5DD-76F2-4C94-9E53-36F787B56F2BQ33819256-0E9AE13E-F7B0-4CF7-AAA4-25682F1006BDQ33944886-414E9491-340F-48E6-9297-91DB9599138EQ34360705-9ECA799B-3A38-4EAD-BB9C-D7B3A401FFF7Q36387010-F2EC9630-9E6A-4032-9FCA-CB9B96E88B40Q36852576-19E8FFDA-DB20-4589-8E90-45B3AA616EB3Q37411544-F86A3C00-F842-4EB6-9547-8DA8DF833364Q37444813-0636476D-164C-4A95-AB7E-940D983C6BD3Q37564992-271F3D05-50E2-481E-B000-8F70A6A76678Q37592033-C5CC4758-38BA-4986-903B-CFAE4FCDFF10Q37650292-FF12265E-422C-4781-9507-339AFA1547B3Q37872360-7F6572B1-F37D-4A30-946E-604BD6BC95A1Q38102053-E1A5257E-49E3-4566-8224-E23F6DB1DA88Q38227110-7826639B-3DA7-4497-B769-02DBDC75D719Q38359027-E1EA56C4-A240-4F66-8C3B-99EFBDFDA684Q39163671-FA0345CF-254C-4B74-97C6-4889497611E0Q39274311-9734CC33-A950-4373-8A84-EFA739F4F425Q39762143-5D42D327-AD4F-4208-AC88-42E4320D4F81Q39775715-8D28C91E-7B85-4BA5-B9D0-4921C81B8154Q42086113-DAB15088-3D57-4F69-9FE6-DD501D43F5B3Q42158814-5E023B65-0DEA-4CD8-B67B-FA8CD0250D70Q44921188-0A824378-1DC5-4B75-A976-66FC8EBE87AEQ47591946-557AF5E4-55B3-4A24-892F-5BA085C3986B
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Therapeutic potential of cannabis in pain medicine
@ast
Therapeutic potential of cannabis in pain medicine
@en
Therapeutic potential of cannabis in pain medicine
@nl
type
label
Therapeutic potential of cannabis in pain medicine
@ast
Therapeutic potential of cannabis in pain medicine
@en
Therapeutic potential of cannabis in pain medicine
@nl
prefLabel
Therapeutic potential of cannabis in pain medicine
@ast
Therapeutic potential of cannabis in pain medicine
@en
Therapeutic potential of cannabis in pain medicine
@nl
P356
P1476
Therapeutic potential of cannabis in pain medicine
@en
P2093
J P Zajicek
R D Hosking
P356
10.1093/BJA/AEN119
P407
P577
2008-07-01T00:00:00Z